Richard A. Fair - 11 Dec 2025 Form 3 Insider Report for Enliven Therapeutics, Inc. (ELVN)

Role
PRESIDENT AND CEO, Director
Signature
/s/ Ben Hohl, by power of attorney
Issuer symbol
ELVN
Transactions as of
11 Dec 2025
Net transactions value
$0
Form type
3
Filing time
12 Dec 2025, 18:30:15 UTC
Previous filing
16 Aug 2022
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Fair Richard A. PRESIDENT AND CEO, Director C/O ENLIVEN THERAPEUTICS, INC., 6200 LOOKOUT ROAD, BOULDER /s/ Ben Hohl, by power of attorney 12 Dec 2025 0001695851

No securities are beneficially owned.

Remarks:

Exhibit 24.1 - Power of Attorney